| Basics |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
|
| IPO Date: |
June 23, 2000 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$396.1M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 3.52%
|
| Avg Daily Range (30 D): |
$0.03 | 3.07%
|
| Avg Daily Range (90 D): |
$0.04 | 4.28%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.35M |
| Avg Daily Volume (30 D): |
2.15M |
| Avg Daily Volume (90 D): |
3.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
264 |
| Avg Trade Size (Sh.) (30 D): |
490 |
| Avg Trade Size (Sh.) (90 D): |
463 |
| Institutional Trades |
| Total Inst.Trades: |
999 |
| Avg Inst. Trade: |
$1.49M |
| Avg Inst. Trade (30 D): |
$3.54M |
| Avg Inst. Trade (90 D): |
$3.54M |
| Avg Inst. Trade Volume: |
.2M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$8.41M |
| Avg Closing Trade (90 D): |
$8.41M |
| Avg Closing Volume: |
193.7K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.33
|
$.01
|
$-.07
|
|
Diluted EPS
|
$-.33
|
$.01
|
$-.07
|
|
Revenue
|
$ 58.43M
|
$ 28.87M
|
$ 1.26M
|
|
Gross Profit
|
$ 57.95M
|
$ 28.83M
|
$ 1.23M
|
|
Net Income / Loss
|
$ -120.62M
|
$ 3.25M
|
$ -25.3M
|
|
Operating Income / Loss
|
$ -118.37M
|
$ 3.74M
|
$ -25.68M
|
|
Cost of Revenue
|
$ .48M
|
$ .03M
|
$ .03M
|
|
Net Cash Flow
|
$ 14.75M
|
$ -12.52M
|
$ -3.77M
|
|
PE Ratio
|
|
|
|
|
|
|
